Edesa Biotech Inc (EDSA)

Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	66.98% 1.1763	0.7045	0.9534	1.0256	1.4582
Depreciation and Amortization	0.81% 0.0454	0.045	0.046	0.083	0.0273
Operating Income/Loss	19.55% -2.2205	-1.8574	-2.3697	-2.0642	-2.4106
Nonoperating Income/Loss	101.11% 0.3599	0.179	0.6493	0.0793	0.077
Income/Loss From Continuing Operations Before Tax	10.85% -1.8605	-1.6785	-1.7203	-1.9849	-2.3335
Income Tax Expense/Benefit	0.0008	-	-	-	0.0008
Income/Loss From Continuing Operations After Tax	10.90% -1.8613	-1.6785	-1.7203	-1.9849	-2.3343
Net Income/Loss	10.90% -1.8613	-1.6785	15.03	-1.9849	-2.3343
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	16.75	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-